Related Experiment Video
Updated: Sep 21, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Slowing the progression of chronic hepatitis B. Early antiviral therapy can help minimize complications
David B Purow1, Ira M Jacobson
1Division of Gastroenterology and Hepatology, Joan and Sanford I. Weill Medical College of Cornell University, 450 E 69th St, New York, NY 10021, USA.
Abstract:
About 350 million people worldwide have chronic hepatitis B virus (HBV) infection. Up to 40% of persons infected with the virus may go on to have complications related to cirrhosis or hepatocellular carcinoma. Antiviral therapy can suppress viral replication and halt the progression of liver disease in persons with chronic infection. In this article, the authors explore the modes of HBV transmission, describe the characteristics of chronic infection, and review the drugs available to treat it.
Related Concept Videos
Hepatitis
Retrovirus Life Cycles
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Antiviral Nucleoside Inhibitors
